Company intelligence / Profile preview

BioDlink

Suzhou, Jiangsu, China

Ownership: Private
Employees: ~611
Development stage: Other

Overview

The company operates a commercial-scale GMP manufacturing base for ADCs and monoclonal antibodies, enables commercial manufacture for several marketed products, and supports development spanning R&D to commercial stages for oncology biologics and ADCs[1][3][4].

Therapeutic areas: Oncology
Modalities: Monoclonal antibodyAntibody-drug conjugateBiologic
Industry: Contract Manufacturing Organization

Partnerships

Multiple strategic partnerships with domestic and international pharma companies for CDMO services

Beyond the preview

Go deeper on BioDlink.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioDlink.

Explore the full profile